Fresenius Medical Care Q2 FY26 operating income excluding special items rises 23% to EUR 569 million; revenue increases 4% to EUR 4.86 billion
Reuters2026/08/03 17:01- Fresenius Medical Care posted Q2 2026 operating income excluding special items of EUR 569 million, up 23% from a year earlier.
- That result topped the market consensus of EUR 515 million, helped by stronger-than-expected growth in the Care Delivery segment.
- Revenue rose 4% to EUR 4.86 billion, slightly ahead of the EUR 4.79 billion consensus estimate.
- The group confirmed its unchanged full-year 2026 outlook.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
Crypto prices
More
